BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6094348)

  • 1. Effects of methyldopa metabolites on amine transmitters and adrenergic receptors in rat brain.
    Louis WJ; Conway E; Summers R; Beart P; Jarrott B
    Hypertension; 1984; 6(5 Pt 2):II40-4. PubMed ID: 6094348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive metabolites of alpha-methyldopa.
    Robertson D; Tung CS; Goldberg MR; Hollister AS; Gerkens JF; Oates JA
    Hypertension; 1984; 6(5 Pt 2):II45-50. PubMed ID: 6094349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in brain alpha-adrenergic receptors after alpha-methyldopa administration to spontaneously hypertensive rats.
    Freed CR; Wang CH; U'Prichard DC
    Hypertension; 1984; 6(5 Pt 2):II34-9. PubMed ID: 6094347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual alpha adrenergic receptor potency of methyldopa metabolites on melanocyte function.
    Pettinger WA
    J Pharmacol Exp Ther; 1977 Jun; 201(3):622-6. PubMed ID: 16998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Methylepinephrine, a methyldopa metabolite that binds to alpha-receptors in rat brain.
    Goldberg MR; Gerkens JF; Oates JA; Robertson D
    Eur J Pharmacol; 1981 Jan; 69(1):95-9. PubMed ID: 6258943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In summary: satellite symposium on central alpha-adrenergic blood pressure regulating mechanisms.
    Abrams WB
    Hypertension; 1984; 6(5 Pt 2):II87-93. PubMed ID: 6150004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological effects of alpha-methyldopa, alpha-methylnorepinephrine, and octopamine on rat arteriolar, arterial, and terminal vascular smooth.
    Altura BM
    Circ Res; 1975 Jun; 36(6 Suppl 1):233-40. PubMed ID: 1093755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of acute alpha-methyldopa administration on catecholamine levels in anterior hypothalamic-preoptic and medullary nuclei in rat brain.
    Conway EL; Louis WJ; Jarrott B
    Neuropharmacology; 1979 Mar; 18(3):279-86. PubMed ID: 375118
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence that alpha-methylepinephrine is an antihypertensive metabolite of alpha-methyldopa.
    Goldberg MR; Tung CS; Ring M; Oates JA; Gerkens JF; Robertson D
    Clin Exp Hypertens A; 1982; 4(4-5):595-604. PubMed ID: 7105433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-methyldopa reduces locomotor activity in rats via its metabolite, alpha-methylnorepinephrine, acting on alpha 2-adrenoceptors.
    Clineschmidt BV; Flataker LM; Faison EP; Haubrich DR
    Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):231-43. PubMed ID: 6250499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential competition by L-alpha-methyldopa metabolites for adrenergic receptors in rat forebrain.
    Goldberg MR; Tung CS; Feldman RD; Smith HE; Oates JA; Robertson D
    J Pharmacol Exp Ther; 1982 Mar; 220(3):552-60. PubMed ID: 7062266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of carbidopa to alpha-methyldopamine and alpha-methylnorepinephrine in rats.
    Shelton RC; Karoum F; Chuang LW; Wyatt RJ
    Biochem Pharmacol; 1985 Oct; 34(20):3623-6. PubMed ID: 3902027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous and alpha-methylated catecholamine levels in anterior hypothalamic-preoptic and medullary nuclei in rat brain after chronic alpha-methyldopa administration.
    Conway EL; Louis WJ; Jarrott B
    Neuropharmacology; 1979 Mar; 18(3):287-90. PubMed ID: 440536
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of acute alpha-methyldopa administration on catecholamine levels in anterior hypothalamic-preoptic and medullary nuclei in rat brain [proceedings].
    Conway EL; Jarrott B; Louis WJ; Beart PM
    Br J Pharmacol; 1978 Mar; 62(3):405P-406P. PubMed ID: 638336
    [No Abstract]   [Full Text] [Related]  

  • 15. Central and peripheral cardiovascular effects of alpha-methylepinephrine.
    Tung CS; Goldberg MR; Hollister AS; Oates JA; Robertson D
    J Pharmacol Exp Ther; 1983 Nov; 227(2):484-90. PubMed ID: 6355433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of brainstem epinephrine stores by alpha-methyldopa: possible relation to attenuated sympathetic outflow.
    Tung CS; Goldberg MR; Hollister AS; Sweetman BJ; Robertson D
    Life Sci; 1988; 42(23):2365-71. PubMed ID: 3287081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alpha-methyldopa and its metabolites on prolactin release: in vivo and in vitro studies.
    Wiggins JF; Sved AF; Fernstrom JD
    J Pharmacol Exp Ther; 1980 Feb; 212(2):304-8. PubMed ID: 6766188
    [No Abstract]   [Full Text] [Related]  

  • 18. The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine.
    van Zwieten PA; Thoolen MJ; Timmermans PB
    Hypertension; 1984; 6(5 Pt 2):II28-33. PubMed ID: 6094346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitation of the alpha-methylnorepinephrine hypothesis in the hypotensive effect of alpha-methyldopa.
    Tung CS; Chen SZ; Hsu CH; Tseng CJ
    Clin Exp Hypertens A; 1989; 11(1):45-58. PubMed ID: 2653670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereochemical course in vivo of alpha-methyldopa decarboxylation in rat brains.
    Ames MM; Melmon KL; Castagnoli N
    Biochem Pharmacol; 1977 Oct; 26(19):1757-62. PubMed ID: 334182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.